Insilico-Medicine

2 observations filed under this label.

AI Drug Discovery's Moment of Truth: A $2.75B Bet, Zero Approvals, and the Drug That Could Change Both

Eli Lilly just wagered up to $2.75 billion on AI-designed medicines, yet not one AI-discovered drug has full FDA approval. Here's why 2026 is the year the field finally gets tested against clinical reality.

The First AI-Designed Drug Just Entered Phase III. Here's What That Actually Proves.

Insilico Medicine has pushed rentosertib, a drug whose target and molecule were both generated by AI, into a pivotal Phase III trial. It's the clearest test yet of whether AI drug discovery can produce medicines that work, not just headlines.